Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
Smith & Nephew Plc |
LSE:SN. |
London |
Ordinary Share |
GB0009223206 |
ORD USD0.20 |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
9.50 |
0.66% |
1,445.00 |
1,446.00 |
1,446.50 |
1,459.00 |
1,431.50 |
1,445.00 |
3,562,633 |
16:35:22 |
Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
Health Care Equipment & Services |
3,335.3 |
179.9 |
37.5 |
39.0 |
12,654 |
Smith & Nephew Share Discussion Threads

Showing 951 to 974 of 975 messages
Date | Subject | Author | Discuss |
---|
06/4/2021 20:48 | Every little helps! US cracking on with their vaccinations too... |  hubshank | |
06/4/2021 14:26 | This is a global organisation, UK a relatively small part of revenue. |  essentialinvestor | |
01/4/2021 12:04 | My local paper has just run an article saying more than 2,200 covid patients discharged and now focussing on procedure wiating list.
London will be doing the same as I saw article other day saying no new cases in London. |  hubshank | |
01/4/2021 09:52 | Added as well. Poor sentiment and expected newsflow very much in the price. Any slight expectation of a pick up or bid and we could be 20% higher quite quickly. Hopefully the downside is limited. |  its the oxman | |
31/3/2021 22:08 | Welcome aboard. |  timbo_slice | |
31/3/2021 18:36 | Bought in. Elective surgery should surge during the summer. Can see this returning to the 1600-1700p range. |  justiceforthemany | |
10/3/2021 18:01 | Susceptible to a bid from Stryker I think! |  ianood | |
10/3/2021 12:14 | Yep, great industry to be in, will hugely benefit from an aging population |  spoole5 | |
10/3/2021 10:22 | Depressed by covid, fundamental value remains and agree a bid is more likely than ever. |  its the oxman | |
03/3/2021 14:51 | Will be vulnerable to a bid soon at these levels |  spoole5 | |
03/3/2021 14:40 | Pricy still. |  essentialinvestor | |
02/3/2021 15:10 | Good to see clarification of the multiples I posted last week.
As someone mentioned to me who disputed the figures
...perhaps it's about the quality of your information.
Yes, perhaps it is. |  essentialinvestor | |
02/3/2021 13:25 | Questor: Smith & Nephew may have grazed its knees with Covid, but it has plenty of fight left
Questor share tip: cancelled surgeries have reduced the need for medical supplies, but demand could well bounce back after lockdown
Smith & Nephew could deliver some pleasant surprises in 2021 and beyond. Hold.
Questor says: hold
https://www.telegraph.co.uk/investing/shares/questor-smith-nephew-may-have-grazed-knees-covid-has-plenty/ |  philanderer | |
25/2/2021 13:56 | With defensive qualities 30% in 2 years will do me. |  piano man | |
23/2/2021 16:37 | Unlikely to take 2 years |  spoole5 | |
23/2/2021 16:31 | My Dad uses professional data, will check with him but he's not
available atm.
To make USD1.85, that's an 80% increase on FY 2019,
I can't square that number with anything I've looked at.
The 2019 FY is pre Covid-19 earnings. |  essentialinvestor | |
23/2/2021 16:24 | My source gives a consensus forecast PE of US$1.85, approx £1.30, so around 11 times at £14. |  gclark | |
23/2/2021 16:23 | That's peak pre Covid-19 earnings.
You are looking at a 2 year recovery to get back to that?. |  essentialinvestor | |
23/2/2021 16:21 | Just under 20 not overly expensive given the significant growth opportunities |  spoole5 | |
23/2/2021 16:17 | Well I'm looking at the adjusted EPS for 2019 at $1.02 (which allows for any (exceptionals).
year ending 31/12/2019 - pre Covid-19 hitting.
On current FX that gives a PE of just under 20 X.
How are you getting 10 X earnings. |  essentialinvestor | |
23/2/2021 16:11 | I see it on a forward forecast PE for 2021 of 10, at a share price of £14, which is not steep.
xxx://money.cnn.com/quote/forecast/forecast.html?symb=SNN
It seems like a decent source of information but we are all limited by our information source! |  gclark | |
23/2/2021 13:53 | spoole, I've looked at FY 2018 EPS, which was the recent peak and flattered
by a legal settlement and still get what appears a pricy multiple.
As SN report in USD, you need to convert earnings in to GBP to calculate. |  essentialinvestor | |
23/2/2021 13:48 | I don't think anyone can accurately predict any earnings for companies hit by covid. |  spoole5 | |
23/2/2021 13:30 | * 24 X FY 2022 earnings estimates, I've not got FY 2023 numbers. |  essentialinvestor | |